Athira Pharma Company Insiders

Athira Pharma Management Team Effectiveness

The company has return on total asset (ROA) of (0.4753) % which means that it has lost $0.4753 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8457) %, meaning that it created substantial loss on money invested by shareholders. Athira Pharma's management efficiency ratios could be used to measure how well Athira Pharma manages its routine affairs as well as how well it operates its assets and liabilities. As of December 2, 2024, Return On Tangible Assets is expected to decline to -0.77. In addition to that, Return On Capital Employed is expected to decline to -1. At present, Athira Pharma's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 1.1 M, whereas Net Tangible Assets are forecasted to decline to about 175.1 M. As of December 2, 2024, Common Stock Shares Outstanding is expected to decline to about 33.7 M. The current year's Net Loss is expected to grow to about (81.8 M)

Athira Pharma Workforce Comparison

Athira Pharma Insider Trading

Athira Pharma Notable Stakeholders

The success or failure of an entity such as Athira Pharma often depends on how effective the management is. Athira Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Athira management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Athira management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Athira Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Athira Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Athira Pharma's management manipulating its earnings.

When running Athira Pharma's price analysis, check to measure Athira Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athira Pharma is operating at the current time. Most of Athira Pharma's value examination focuses on studying past and present price action to predict the probability of Athira Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athira Pharma's price. Additionally, you may evaluate how the addition of Athira Pharma to your portfolios can decrease your overall portfolio volatility.